摘要
2013年底,有媒体报道湖南省多地婴儿接种乙肝疫苗后出现严重不良反应,之后在自媒体新闻的传播下,有关该事件的报道不断发酵。在对企业疫苗生产现场GMP检查、疫苗检验和病例调查的基础上,国家卫计委和药监局公布该事件与乙肝疫苗质量无关。但该事件造成我国计划免疫疫苗接种率大幅下降,给传染病防控工作带来了巨大挑战。本文对本次乙肝疫苗事件在自媒体时代的传播及影响进行分析,总结该事件对疫苗监管带来的反思。
At the end of 2013, several media reported the serious adverse reactions when people took hepatitis B vaccination in Hunan province. Then the news spread from we-media platform, and the event kept simmering. Based on the GMP inspection, vaccine inspection and case investigation, NHFPC and CFDA announced that the event had nothing to do with hepatitis B vaccine quality. However, the incident caused sharply decrease of EPI vaccination rate in China, which brought great challenges to the prevention and control of infectious diseases. In this paper, we analyzed the spread and infl uence of the ＂hepatitis B vaccine event＂ in wemedia era, and summarized the refl ections on the vaccine regulation.
出处
《中国药事》
CAS
2015年第9期904-907,共4页
Chinese Pharmaceutical Affairs
基金
"十二五"传染病国家科技重大专项课题(编号2012ZX10004701)
关键词
乙肝疫苗事件
自媒体
反思
hepatitis B vaccine event
we-media
refl ection
